CAS: 2209085-22-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | JH-XI-10-02 REF: TM-T13743CAS: 2209085-22-1 | 98% | To inquire | Tue 21 Jan 25 |
 | Jh-xi-10-02 REF: 3D-JND08522CAS: 2209085-22-1 | Min. 95% | 898.00 €~11,462.00 € | Mon 03 Mar 25 |
JH-XI-10-02
CAS:2209085-22-1
JH-XI-10-02 selectively degrades CDK8 (IC50: 159 nM) through proteasome, sparing CDK8 mRNA and CDK19.
Formula:
C53H69N5O9
Purity:
98%
Color and Shape:
Solid
Molecular weight:
920.161
Ref: TM-T13743
| 2mg | 1,366.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Jh-xi-10-02
CAS:2209085-22-1
Jh-xi-10-02 is a heterobifunctional molecule that inhibits ubiquitin ligases and targets cancer cells. It is …
Formula:
C53H69N5O9
Purity:
Min. 95%
Molecular weight:
920.14 g/mol
Ref: 3D-JND08522
| 1mg | 898.00 € | ||
| 5mg | 2,388.00 € | ||
| 10mg | 3,821.00 € | ||
| 25mg | 7,164.00 € | ||
| 50mg | 11,462.00 € |
Estimated delivery in United States, on Monday 3 Mar 2025
